FDA — authorised 17 August 1939
- Marketing authorisation holder: ORGANON USA INC
- Status: approved
🇺🇸 Sincortex in United States
FDA authorised Sincortex on 17 August 1939
Marketing authorisations
FDA — authorised 9 December 1942
- Application: NDA005151
- Marketing authorisation holder: NOVARTIS
- Local brand name: PERCORTEN
- Indication: PELLET — IMPLANTATION
- Status: approved
Sincortex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Sincortex approved in United States?
Yes. FDA authorised it on 17 August 1939; FDA authorised it on 9 December 1942.
Who is the marketing authorisation holder for Sincortex in United States?
ORGANON USA INC holds the US marketing authorisation.